cannogenol-3-o-beta-d-allomethyloside has been researched along with calotropin in 1 studies
*calotropin: structure in first source [MeSH]
*calotropin: structure in first source [MeSH]
| Studies (cannogenol-3-o-beta-d-allomethyloside) | Trials (cannogenol-3-o-beta-d-allomethyloside) | Recent Studies (post-2010) (cannogenol-3-o-beta-d-allomethyloside) | Studies (calotropin) | Trials (calotropin) | Recent Studies (post-2010) (calotropin) |
|---|---|---|---|---|---|
| 7 | 0 | 2 | 19 | 0 | 12 |
| Protein | Taxonomy | cannogenol-3-o-beta-d-allomethyloside (IC50) | calotropin (IC50) |
|---|---|---|---|
| Neurogenic locus notch homolog protein 1 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Tarboush, FM; AbulFarah, M; Al-Anazi, FS; Al-Anazi, KM; Al-Hemaid, F; Ali, MA; Bhattacharjee, A; Gurung, AB; Lee, J | 1 |
1 other study(ies) available for cannogenol-3-o-beta-d-allomethyloside and calotropin
| Article | Year |
|---|---|
Molecular docking of the anticancer bioactive compound proceraside with macromolecules involved in the cell cycle and DNA replication.
Topics: Antineoplastic Agents; Cardenolides; Cardiac Glycosides; Cell Cycle; Cell Line, Tumor; Digitoxigenin; DNA Replication; Humans; Ligands; Macromolecular Substances; Molecular Docking Simulation; Structure-Activity Relationship | 2016 |